Biotech IPOs Raise $1B in Biggest Week Since 2021
Four drug companies went public this week raising nearly $1 billion combined, led by Eikon Therapeutics' $381M offering — the largest biotech IPO since 2024.
By Sarah Chen
10 articles
Four drug companies went public this week raising nearly $1 billion combined, led by Eikon Therapeutics' $381M offering — the largest biotech IPO since 2024.
By Sarah Chen
IPO activity accelerates with Public Policy Holding Company among notable debuts. 2026 pipeline signals potential AI-led mega wave ahead.
Space company targets $1.5 trillion valuation in what could be the largest public offering ever. Starlink spin-off plans shelved.
2026 could see largest venture-backed listings ever at combined $2.5 trillion valuation. Historical data shows 49% average losses three years out.
With 9 million subscribers and projected $22B revenue, Starlink appears ready for a 2026 IPO. But several factors could still push the timeline.
Shanghai Biren Technology's $717 million Hong Kong IPO draws massive investor demand as Chinese AI chipmakers race to challenge NVIDIA's dominance.
Kunlunxin, Baidu's AI chip subsidiary, has confidentially filed for a Hong Kong listing as China's tech sector seeks to capitalize on AI momentum.
Indian companies raised the highest annual total ever in 2025, surpassing 100 mainboard IPOs for the first time since 2007 as domestic investors power the boom.
Elon Musk confirmed SpaceX will go public in 2026, giving investors access to the Starlink satellite internet business that now serves 8 million customers.
Medical supplies giant Medline raised $6.26 billion in the largest U.S. IPO since Rivian's 2021 offering, with shares jumping 41% on debut.